BSE filing, NSE: KANORICHEM. Summary written from the filing by ALFA Finder's alert engine.
Kanoria Chemicals & Industries Ltd: key numbers
- Share price
- ₹178.52
- Market cap
- ₹780.0 Cr
- Revenue (annual)
- ₹981.4 Cr
- Net profit (annual)
- ₹120.8 Cr
- P/E (TTM)
- 5.0×Sector 34.1×
- Promoter holding
- 74.40%+0.00% QoQ
- FII holding
- 0.07%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Kanoria Chemicals & Industries Ltd
All →Kanoria Chemicals & Industries Other Announcement
Kanoria Chemicals & Industries Ltd submitted its quarterly shareholding pattern for the period ending September 30, 2026, as required under SEBI regulations.
Kanoria Chemicals & Industries Capacity Expansion
Kanoria Chemicals announced a new 12 TPD Triacetin manufacturing facility at its existing site in Ankleshwar, Gujarat, to strengthen its specialty chemicals portfolio.
- manufacturing capacity
- 12.0 TPD
Kanoria Chemicals & Industries Credit Rating
Infomerics rated Kanoria Chemicals' long-term bank facilities IVR BBB-/Stable and short-term facilities IVR A3. The rating covers a total of Rs.162.07 Crore in rated bank loan facilities.
Kanoria Chemicals & Industries Investor Presentation: Key Takeaways
Kanoria Chemicals reported strong FY26 performance with 30% consolidated revenue growth and 90% EBITDA growth. Management highlights operational efficiencies and a strategic 'Vision 2030' roadmap.
Kanoria Chemicals & Industries Annual General Meeting
Kanoria Chemicals & Industries Limited conducted its 66th Annual General Meeting on September 2, 2026, via video conferencing. The meeting covered routine ordinary and special business resolutions.
Kanoria Chemicals & Industries Q1 FY27 Results: Turns Profitable, Net Profit ₹26.4 Cr
Kanoria Chemicals & Industries Ltd reported revenue from operations of ₹460.4 Cr (+128.6% YoY) and net profit of ₹26.4 Cr for Q1 FY27.
- Key figure
- Net profit ₹26.4 Cr
Other board meeting outcome announcements
All →R R Kabel Board Meeting Outcome
RR Kabel's board approved amendments to its UPSI fair disclosure code on 28 October 2026. The amended code is enclosed and posted on the company website.
M K Exim (India) Board Meeting Outcome
M.K. Exim (India) approved shifting its registered office within Jaipur to Plot J-1247, Sitapura. The board meeting was held on October 28, 2026.
United Spirits Board Meeting Outcome
United Spirits' board approved amendments to its insider trading code on 28 October 2026, effective 29 October 2026. The revised code is available on the company website.
SBI Funds Management Board Meeting Outcome
SBI Funds Management extended internal auditor Chhajed & Doshi's term to March 31, 2030. This routine decision was taken at the October 28, 2026 board meeting.
- Execution
- April 1, 2028 to March 31, 2030
Paras Healthcare Board Meeting Outcome
Paras Healthcare filed its board-approved UPSI fair disclosure code under Regulation 8(2). This routine governance policy update reports no business event.
Gateway Distriparks Board Meeting Outcome
Gateway Distriparks' board approved a revised Code of Practices for Fair Disclosure of UPSI under PIT Regulation 8(2). This is a routine governance policy update with no business event.